You’re in the middle of a q-bank block, and the stem screams “antipsychotic,” but the answer choices are a minefield: EPS vs NMS vs metabolic syndrome vs agranulocytosis vs QT prolongation. This is exactly the kind of question where knowing one drug fact isn’t enough—you need to know why each distractor is wrong and what it would have looked like if it were right.
Tag: Psychiatry > Psychotic & Mood Disorders
The Vignette (Classic USMLE Style)
A 28-year-old man with schizophrenia is brought to clinic by his sister because he has become increasingly withdrawn and is “staring off” for the last month. He reports hearing voices and believes coworkers can read his thoughts. He was started on a new medication 10 days ago. Today he has high fever, severe generalized muscle rigidity, confusion, diaphoresis, and tachycardia. Exam shows lead-pipe rigidity. Labs show markedly elevated creatine kinase and leukocytosis.
Question: Which medication is the most likely cause?
Answer choices:
A. Haloperidol
B. Clozapine
C. Quetiapine
D. Fluoxetine
E. Lithium
Step-by-Step: What’s Going On?
This is neuroleptic malignant syndrome (NMS) until proven otherwise.
Why it’s NMS
High-yield NMS pattern:
- Trigger: dopamine blockade (usually high-potency typical antipsychotics)
- Timing: days to weeks after initiation or dose increase
- Key findings:
- Hyperthermia
- “Lead-pipe” rigidity (not clonus)
- Autonomic instability (tachycardia, labile BP, diaphoresis)
- Altered mental status
- Elevated CK from rhabdomyolysis
Mechanism (USMLE version)
- D2 receptor blockade in the nigrostriatal pathway + hypothalamic dysregulation → rigidity + hyperthermia.
Treatment (testable)
- Stop the offending agent
- Supportive care (IV fluids, cooling)
- Dantrolene (muscle relaxant; inhibits ryanodine receptor)
- Bromocriptine (dopamine agonist)
- Amantadine (↑ dopamine release)
Correct Answer: A. Haloperidol
Haloperidol is a high-potency typical antipsychotic → strongest association with EPS and NMS.
High-yield drug classification
- Typical (1st gen): strong D2 blockade
- High potency: Haloperidol, Fluphenazine, Trifluoperazine
- Low potency: Chlorpromazine, Thioridazine
- Atypical (2nd gen): 5-HT2A antagonism + D2 blockade (less EPS overall)
Now Destroy the Distractors (What They’re Trying to Trick You With)
B. Clozapine — tempting because it’s “dangerous,” but wrong for this stem
Clozapine is an atypical antipsychotic with:
- Agranulocytosis (most board-famous) → fever + sore throat + infections, low ANC
- Seizures (dose-related)
- Myocarditis
- Metabolic syndrome (weight gain, dyslipidemia, insulin resistance)
- Sialorrhea (excess drooling—oddly common)
Why it’s wrong here:
This patient has lead-pipe rigidity + very high CK, pointing to NMS, not isolated neutropenic fever.
What the stem would look like if it were clozapine:
- Recurrent infections, oral ulcers, fever with neutropenia
- Or chest pain + dyspnea early in treatment (myocarditis)
High-yield monitoring:
- ANC monitoring: typically weekly at first, then spaced out (exam wants: must monitor ANC).
C. Quetiapine — atypical with sedation/metabolic effects, not classic NMS
Quetiapine is an atypical antipsychotic, notable for:
- Sedation (H1 blockade)
- Orthostatic hypotension (α1 blockade)
- Metabolic syndrome (weight gain, hyperglycemia; class effect, especially olanzapine/clozapine)
Why it’s wrong here:
Atypicals can rarely cause NMS, but boards usually point to high-potency typicals when the vignette is “textbook NMS.” Also, the stem strongly emphasizes rigidity/CK—classic for dopamine blockade maximally, i.e., haloperidol.
What the stem would look like if it were quetiapine:
- Daytime somnolence, weight gain, new diabetes, orthostasis—rather than severe rigidity and CK spike.
D. Fluoxetine — this is where they’re testing NMS vs serotonin syndrome
Fluoxetine (SSRI) could cause serotonin syndrome, which can look superficially similar (fever, autonomic instability, AMS). The differentiator is neuromuscular findings.
NMS vs Serotonin Syndrome (must-know table)
| Feature | NMS | Serotonin Syndrome |
|---|---|---|
| Trigger | Dopamine antagonists (antipsychotics) | Serotonergic meds (SSRIs, MAOIs, linezolid, tramadol, MDMA, triptans) |
| Onset | Days–weeks | Hours–1 day |
| Muscle tone | Lead-pipe rigidity | Hyperreflexia, clonus (esp. inducible/ocular) |
| Pupils | Normal | Dilated often |
| Bowel sounds | Normal | Hyperactive, diarrhea |
| Key lab | ↑ CK | May have ↑ CK but neuro exam points to clonus |
Why it’s wrong here:
No clonus/hyperreflexia, and timing aligns better with NMS after antipsychotic initiation.
Treatment for serotonin syndrome (high-yield):
- Stop agent, supportive care
- Benzodiazepines
- Cyproheptadine (5-HT2 antagonist)
E. Lithium — important mood stabilizer toxicity pattern, different clinical picture
Lithium toxicity typically causes:
- GI: nausea, vomiting, diarrhea
- Neuro: coarse tremor, ataxia, confusion, seizures
- Cardiac: T-wave flattening/inversion, arrhythmias
- Renal/endocrine: nephrogenic DI, hypothyroidism
Why it’s wrong here:
Lithium toxicity doesn’t classically cause lead-pipe rigidity + massive CK. Also the stem’s “new medication 10 days ago” in a patient with schizophrenia points toward antipsychotics rather than a mood stabilizer.
High-yield interactions (testable): “Lithium levels go up with anything that lowers GFR or sodium.”
- Thiazides
- NSAIDs
- ACE inhibitors/ARBs
- Dehydration
High-Yield Antipsychotic Framework (So You Don’t Miss Future Questions)
Receptor logic = side effects
Think of typical/atypical antipsychotics as a receptor tradeoff.
Typical antipsychotics (D2 blockade heavy)
- Benefits: great for positive symptoms (hallucinations, delusions)
- Costs: EPS, hyperprolactinemia, NMS
D2 blockade pathways (boards love this):
- Nigrostriatal: EPS (acute dystonia, akathisia, Parkinsonism, tardive dyskinesia)
- Tuberoinfundibular: ↑ prolactin → galactorrhea, amenorrhea, sexual dysfunction
- Mesolimbic: ↓ positive symptoms (desired)
Atypical antipsychotics (5-HT2A antagonism + D2 blockade)
- Benefits: fewer EPS/hyperprolactin (overall), some help with negative symptoms
- Costs: metabolic syndrome, variable QT prolongation, sedation/orthostasis depending on drug
EPS: Timing + Treatment (Quick Board-Ready List)
| Side effect | Onset | Classic clue | Treatment |
|---|---|---|---|
| Acute dystonia | Hours–days | torticollis, oculogyric crisis | Benztropine or diphenhydramine |
| Akathisia | Days–weeks | “can’t sit still” | Propranolol (or benzo) |
| Parkinsonism | Weeks–months | rigidity, bradykinesia, tremor | Benztropine or amantadine |
| Tardive dyskinesia | Months–years | lip smacking, choreoathetoid movements | VMAT2 inhibitors (valbenazine, deutetrabenazine); stop/switch drug |
Pearl: EPS risk is highest with high-potency typicals (haloperidol, fluphenazine).
Exam Pitfalls to Anticipate
- Fever + rigidity + autonomic instability after antipsychotic → NMS (think haloperidol).
- Fever + clonus + hyperreflexia + diarrhea after serotonergic meds → serotonin syndrome.
- Clozapine is the “special case” atypical:
- used for treatment-resistant schizophrenia
- reduces suicide risk
- but requires ANC monitoring due to agranulocytosis
- Low-potency typicals (chlorpromazine, thioridazine) have more:
- anticholinergic effects (dry mouth, constipation, urinary retention)
- sedation
- orthostatic hypotension
- and specific tox: corneal deposits (chlorpromazine), retinal deposits/QT prolongation (thioridazine)
Takeaway: Why Every Answer Choice Matters
This question isn’t just “NMS = haloperidol.” It’s training you to:
- recognize core syndromes (NMS vs serotonin syndrome vs toxicity)
- link receptor pharmacology to side effects
- predict what the vignette would look like for each distractor
If you can explain why clozapine would cause neutropenic fever, quetiapine would cause sedation/metabolic issues, fluoxetine would cause clonus-heavy serotonin syndrome, and lithium would cause tremor/ataxia/GI symptoms—you’ll stop guessing and start pattern-matching like a resident.